Cyclo Therapeutics Enters into Note Purchase Agreement with Rafael HoldingsCyclo Therapeutics, Inc. (NASDAQ:CYTH) announced today that it has entered into a Sixth Amended and Restated Note Purchase Agreement with Rafael Holdings, Inc., a Delaware cor
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cyclo Therapeutics’s 8K filing here. About Cyclo Therapeutics (Get Free Report) Cyclo Therapeutics, Inc, a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. […]
More Stories
Ilhan Omar, Broken Vetting, and Minnesota’s Billion-Dollar Fraud: The Questions That Will Not Die
By Stephen Zogopoulos, USNN World News The federal investigation into Rep. Ilhan Omar’s immigration history and the massive public-benefits fraud...
Democrats Sue Trump Admin Over Bid to Clean Up Voter Rolls
By Zachary Stieber Senate Minority Leader Chuck Schumer (D-N.Y.) and other Democrats have sued the Trump administration over its effort...
Implementing Freight Management Software: In-House or With Specialist Help?
You’ve picked a freight platform. Now you have to get it live without stopping trucks, missing invoices or losing track...
DOGE Illegally Accessed Data on Government Workers: Judge
By Zachary Stieber A federal judge ruled on Oct. 20 that a department aimed at making the government more efficient...
UK Rearrests 2 Men Over Suspected Terror Plot at Air Base
By Jill McLaughlin UK police have rearrested two men, suspected of working for Iran’s intelligence service, for allegedly plotting to...
$245 Million Taxpayer-Backed Loan to Fund Naval Shipbuilding Facilities
By AAP Australia will lend hundreds of millions of dollars to the nation’s largest shipbuilder for a massive new manufacturing...